| Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 E Whittaker, A Bamford, J Kenny, M Kaforou, CE Jones, P Shah, ... Jama 324 (3), 259-269, 2020 | 2244 | 2020 |
| Using the Delphi technique to determine which outcomes to measure in clinical trials: recommendations for the future based on a systematic review of existing studies IP Sinha, RL Smyth, PR Williamson PLoS medicine 8 (1), e1000393, 2011 | 962 | 2011 |
| Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study OV Swann, KA Holden, L Turtle, L Pollock, CJ Fairfield, TM Drake, S Seth, ... bmj 370, 2020 | 760 | 2020 |
| A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process R Harwood, B Allin, CE Jones, E Whittaker, P Ramnarayan, AV Ramanan, ... The Lancet Child & Adolescent Health 5 (2), 133-141, 2021 | 414 | 2021 |
| COVID-19 infection in children IP Sinha, R Harwood, MG Semple, DB Hawcutt, R Thursfield, O Narayan, ... The Lancet. Respiratory Medicine 8 (5), 446, 2020 | 256 | 2020 |
| A systematic review of studies that aim to determine which outcomes to measure in clinical trials in children I Sinha, L Jones, RL Smyth, PR Williamson PLoS medicine 5 (4), e96, 2008 | 228 | 2008 |
| Development of a core outcome set for clinical trials in childhood asthma: a survey of clinicians, parents, and young people IP Sinha, R Gallagher, PR Williamson, RL Smyth Trials 13, 1-9, 2012 | 172 | 2012 |
| Corticosteroids for treating hypotension in preterm infants H Ibrahim, IP Sinha, NV Subhedar Cochrane Database of Systematic Reviews, 2011 | 136 | 2011 |
| Core outcome sets J Webbe, I Sinha, C Gale Archives of disease in childhood-Education and practice 103 (3), 163-166, 2018 | 124 | 2018 |
| CPAP and high-flow nasal cannula oxygen in bronchiolitis IP Sinha, AKS McBride, R Smith, RM Fernandes Chest 148 (3), 810-823, 2015 | 123 | 2015 |
| Children's emergency presentations during the COVID-19 pandemic D Roland, R Harwood, N Bishop, D Hargreaves, S Patel, I Sinha The Lancet Child & Adolescent Health 4 (8), e32-e33, 2020 | 107 | 2020 |
| Transmission of paediatric respiratory syncytial virus and influenza in the wake of the COVID-19 pandemic TC Williams, I Sinha, IG Barr, M Zambon Eurosurveillance 26 (29), 2100186, 2021 | 106 | 2021 |
| The COVID-19 pandemic: adverse effects on the social determinants of health in children and families EM Abrams, M Greenhawt, M Shaker, AD Pinto, I Sinha, A Singer Annals of Allergy, Asthma & Immunology 128 (1), 19-25, 2022 | 97 | 2022 |
| Novel paediatric presentation of COVID-19 with ARDS and cytokine storm syndrome without respiratory symptoms CE Pain, S Felsenstein, G Cleary, S Mayell, K Conrad, S Harave, ... The Lancet. Rheumatology 2 (7), e376, 2020 | 85 | 2020 |
| Ethnicity and outcomes from COVID-19: the ISARIC CCP-UK prospective observational cohort study of hospitalised patients EM Harrison, AB Docherty, B Barr, I Buchan, G Carson, TM Drake, ... SSRN Electronic Journal, 2020 | 81 | 2020 |
| Standard 5: selection, measurement, and reporting of outcomes in clinical trials in children IP Sinha, DG Altman, MW Beresford, M Boers, M Clarke, J Craig, ... Pediatrics 129 (Supplement_3), S146-S152, 2012 | 81 | 2012 |
| Pediatric asthma and COVID‐19: The known, the unknown, and the controversial EM Abrams, I Sinha, RM Fernandes, DB Hawcutt Pediatric pulmonology 55 (12), 3573-3578, 2020 | 74 | 2020 |
| Child poverty, food insecurity, and respiratory health during the COVID-19 pandemic IP Sinha, AR Lee, D Bennett, L McGeehan, EM Abrams, SJ Mayell, ... The Lancet Respiratory Medicine 8 (8), 762-763, 2020 | 73 | 2020 |
| Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del) KW Southern, J Murphy, IP Sinha, SJ Nevitt Cochrane Database of Systematic Reviews, 2020 | 70 | 2020 |
| Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis KW Southern, S Patel, IP Sinha, SJ Nevitt Cochrane Database of Systematic Reviews, 2018 | 68 | 2018 |
Dan HawcuttUniversity of LiverpoolVerifierad e-postadress på liv.ac.uk
